RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases. The company also offers its discovery platforms and antiviral services to other biotechnology companies.

The Company’s pipeline includes small-molecule immunomodulators for HIV eradication and antivirals against highly pathogenic arenaviruses, including Lassa Fever Virus (Read more).

RetroVirox was founded with an initial investment by scientists and entrepreneurs to translate early-stage research into cures. RetroVirox has received over $5 million dollars in Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIAID) (Read more)

The Company also offers antiviral testing and customized early stage discovery solutions to other Life Sciences companies working in the antiviral and diagnostics field. RetroVirox provides different opportunities to fulfill the needs of these companies, offering a broad menu of antiviral assays in a fee-for-service or F.T.E. modality, and also offers opportunities to establish  collaborative efforts  (Read more).

RetroVirox is headquartered in San Diego, California

Career opportunities at RetroVirox (Read more)

Antiviral Services (Read more)